|1.||Konturek, S J: 7 articles (01/2002 - 01/2000)|
|2.||Konturek, P C: 7 articles (01/2002 - 01/2000)|
|3.||Smith, Jill P: 6 articles (03/2015 - 12/2002)|
|4.||Varro, Andrea: 6 articles (01/2013 - 07/2002)|
|5.||Wang, Timothy C: 6 articles (09/2009 - 08/2003)|
|6.||Reubi, Jean Claude: 5 articles (06/2015 - 07/2003)|
|7.||Fourmy, Daniel: 5 articles (02/2014 - 10/2002)|
|8.||Béhé, Martin: 5 articles (04/2011 - 01/2002)|
|9.||Schmitz, Frank: 5 articles (12/2010 - 09/2005)|
|10.||Hellmich, Mark R: 5 articles (02/2010 - 12/2002)|
12/01/1999 - "In vivo biodistribution experiments in CA20948 tumor-bearing Lewis rats showed rapid clearance of [111In-DOTA0]CCK8, and specific uptake was found in the CCK-B receptor-expressing stomach and tumor. "
11/03/2014 - "Based on the present study, (68)Ga-DOTA-PP-F11 might be a promising radiopharmaceutical for PET/CT imaging of CCK2 receptor expressing tumors such as MTC and SCLC. "
06/01/1999 - "In a pilot clinical study, radioiodinated and 111In-labeled derivatives showed excellent targeting of physiological CCK-B receptor-expressing organs, as well as all known tumor sites. "
01/01/2015 - "Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers."
11/03/2014 - "All tested radiolabeled compounds clearly visualized the CCK2 receptor positive tumor in PET or SPECT imaging. "
|2.||Thyroid Neoplasms (Thyroid Cancer)
11/01/2006 - "Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma."
12/01/2006 - "Gastrin receptor scintigraphy (GRS) is a new imaging method primarily developed for the detection of metastases of medullary thyroid carcinoma (MTC). "
11/01/2006 - "To determine the clinical performance of gastrin receptor scintigraphy (GRS), it was compared with somatostatin receptor scintigraphy (SRS), computed tomography (CT) and (18)F-FDG positron emission tomography (PET) in patients with metastasised/recurrent medullary thyroid carcinoma (MTC). "
03/01/2003 - "For PRRT of CCK-B receptor-positive tumours, such as medullary thyroid carcinoma, radiolabelled minigastrin analogues are currently being successfully applied. "
02/01/2012 - "Amongst other promising agents, radiolabelled exendin analogues show potential for imaging and possibly therapy of insulinomas, while preclinical studies are currently evaluating DOTA peptides targeting the CCK-2/gastrin receptors that are overexpressed by medullary thyroid carcinoma cells."
|3.||Parkinson Disease (Parkinson's Disease)
08/01/1990 - "We suggest that CCK-B receptor antagonists may be useful adjuncts to existing dopamine replacement therapy for improved management of Parkinson's disease."
06/01/2003 - "Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease."
01/01/1996 - "Since no permanent ECL cell line is at hand for in vitro studies, we established a suitable cell system by stable transfection of a human gastric adenocarcinoma cell line (AGS) with the CCK-B/gastrin receptor. "
01/01/2011 - "Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas."
08/01/1994 - "However, none of the gastric adenocarcinoma cell lines or surgically resected gastric adenocarcinomas tested had any detectable expression of gastrin receptor gene. "
04/01/1992 - "Colonic mucosa and adenocarcinoma are known to possess gastrin receptors. "
09/01/1985 - "Some gastric and colonic adenocarcinomas from both humans and animals have specific gastrin receptors. "
|5.||Pancreatic Neoplasms (Pancreatic Cancer)
02/01/2009 - "The experience of synthesising a novel gastrin receptor antagonist gastrazole and taking it into 3 small clinical studies in pancreatic cancer in man is described. "
02/01/2009 - "Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer."
04/24/2006 - "Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials."
03/01/1997 - "The aim of this study was to determine the effects of activation of CCK(A) and CCK(B) receptors on the growth of human pancreatic cancer cells in vitro. "
03/01/2015 - "Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival."
|2.||Pentetic Acid (DTPA)
|6.||Messenger RNA (mRNA)
|7.||Cholecystokinin B Receptor
|1.||Heterologous Transplantation (Xenotransplantation)